 SOUTH SAN FRANCISCO, Calif. INGELHEIM, Germany--BUSINESS WIRE--Twist Bioscience Corporation NASDAQ:TWST, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a broad-based research collaboration with Boehringer Ingelheim International GmbH to use Twists proprietary antibody libraries to discover therapeutic antibodies against multiple targets provided by Boehringer Ingelheim. Boehringer Ingelheim believes 